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Abstract
BACKGROUND—Hispanics are more likely than other racial/ethnic groups in the United States 
to be diagnosed with later stage of prostate cancer, yet they have lower prostate cancer mortality 
rates. The authors evaluated the impact of nativity and neighborhood-level Hispanic ethnic enclave 
on prostate cancer survival among Hispanics.
METHODS—A total of 35,427 Hispanic men diagnosed with invasive prostate cancer from 1995 
through 2008 in the California Cancer Registry were studied; vital status data were available 
through 2010. Block group-level neighborhood measures were developed from US Census data. 
Stage-stratified Cox proportional hazards models were used to assess the effect of nativity and 
ethnic enclave on prostate cancer survival.
RESULTS—In models adjusted for neighborhood socioeconomic status and other individual 
factors, foreign-born Hispanics were found to have a significantly lower risk of prostate cancer 
survival (hazards ratio [HR], 0.81; 95% confidence interval [95% CI], 0.75–0.87). Living in an 
ethnic enclave appeared to modify this effect, with the survival advantage slightly more 
pronounced in the high ethnic enclave neighborhoods (HR, 0.78; 95% CI, 0.71–0.86) compared 
with low ethnic enclave neighborhoods (HR, 0.86; 95% CI, 0.76–0.98).
CONCLUSIONS—Despite lower socioeconomic status, Hispanic immigrants have better 
survival after prostate cancer than US-born Hispanics and this pattern was more striking among 
those living in ethnic enclaves. Identifying the modifiable individual and neighborhood-level 
factors that facilitate this survival advantage in Hispanic immigrants may help to inform specific 
interventions to improve survival among all patients.
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INTRODUCTION
Of all major races and ethnicities, Hispanics are the most rapidly growing group in the 
United States, particularly in California, where the 14 million residents who are of Hispanic 
origin comprise more than one-third of the total California population.1,2 Hispanics are 
composed of a diverse population from many countries; however in California, the majority 
of foreign-born Hispanics immigrated from Mexico.3 Prostate cancer is the most commonly 
diagnosed cancer and accounts for > 25% of all new cancer cases among US Hispanic 
males.4,5
Compared with non-Hispanic (NH) white men, Hispanic men diagnosed with prostate 
cancer present with more advanced stage of disease, higher tumor grade, and elevated 
prostate-specific antigen levels,5–7 yet they experience lower prostate cancer-specific death 
rates,4,8–10 although this finding has not been consistently observed.11 Foreign-born 
Hispanics living in the United States experience a lower risk of death from prostate cancer 
than both NH whites and US-born Hispanics.9,12 Survival differences among Hispanic men 
do not appear to be entirely explained by treatment differences between NH white and 
Hispanic men,13,14 but may relate to lifestyle factors and degree of acculturation after 
migration to the United States.15,16 A spatial-temporal study performed in Texas found that 
Hispanics who resided in specific counties experienced an excess of prostate cancer 
mortality compared with those residing other counties, indicating that county-level or 
neighborhood-level clustering of sociodemographic factors may be associated with prostate 
cancer outcomes.8
The “Hispanic paradox” refers to the persistent pattern of Hispanic Americans having health 
outcomes that are paradoxically comparable to, or better than, their NH white counterparts 
although Hispanics have lower average socioeconomic status (SES). It has been postulated 
that this paradox reflects a survival advantage among foreign-born Hispanics, who in the 
United States predominantly reside in ethnic enclave communities (neighborhoods with 
higher concentrations of a particular ethnic group with ethnic-specific sociocultural mores) 
and who may experience culture-related health protective effects for a variety of disease 
outcomes. To the best of our knowledge, the current study is the first to investigate prostate 
cancer survival among Hispanics by nativity and ethnic enclave. Teasing apart the 
independent and joint effects of nativity, SES, and residence in ethnic enclaves may help us 
to better understand the apparent paradox in the improved survival, compared with NH white 
men, among Hispanic men diagnosed with prostate cancer, despite their having more 
advanced disease at the time of diagnosis.9,16,17
We examined prostate cancer survival among US-born and foreign-born Hispanics in the 
population-based California Cancer Registry (CCR) from 1995 to 2008. To our knowledge 
such an analysis has not been previously conducted in part due to missing data regarding 
birthplace for a sizable percentage (approximately 25%) of Hispanic cancer cases in CCR 
data.18,19 Therefore, through statistical imputation of nativity for cancer cases with missing 
birthplace and in combination with small-area (block group)–level data on neighborhood 
SES and ethnic enclave, we estimated prostate cancer survival among Hispanic men residing 
in California.
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MATERIALS AND METHODS
Study Population
California law mandates that cancer cases be reported to the population-based CCR, which 
is a participant in the National Cancer Institute’s Surveillance, Epidemiology, and End 
Results program and thus requires the highest level of data quality and accuracy, and is 
estimated to include > 99% of all invasive cancers diagnosed in the state of California. The 
CCR routinely collects patient data from medical records on personal characteristics at time 
of diagnosis (age, sex, race, ethnicity, and residence) as well as tumor characteristics (extent 
of disease, tumor characteristics, and first course of treatment). Through routine linkages 
with state and national databases, the CCR obtains and updates vital status and cause of 
death. Hispanic ethnicity was collected from medical records from inference based on 
additional information such as race and ethnicity of parents, maiden name, surname, and 
birthplace, or from death records.19,20 The North American Association of Central Cancer 
Registries’ Hispanic Identification Algorithm was used to improve the classification of 
Hispanic ethnicity.21
We identified 36,897 California residents of Hispanic ethnicity, regardless of race, newly 
diagnosed with first primary invasive prostate cancer (International Classification of Disease 
for Oncology, 3rd edition [ICD-O-3]22 site code C619) during the period from January 1, 
1995 through December 31, 2008. We limited the study to those individuals with 
adenocarcinoma (ICD-O-3 morphology codes 8010 and 8140–8570). For each prostate 
cancer case, we obtained registry information routinely abstracted from the medical record 
such as age at diagnosis, stage at diagnosis (summarized as local/regional, advanced, or 
unknown), histological grade, and other clinical variables. In addition, address of residence 
at time of diagnosis was collected and geocoded by the CCR and used to assign each 
individual to a census block group.
We excluded subjects with missing or invalid survival time (n = 569) and those subjects 
whose address could not be accurately geocoded to a census block group (n = 901). The 
final population study size for analysis included 35,427 Hispanic men.
Variables
Nativity classification—Data regarding birthplace were available through the CCR for 
60.2% of the identified cases. Statistical imputation using the subject’s Social Security 
number (SSN), which is indicative of the state and year of issuance, was used to estimate 
nativity for the 36.9% of cases with a known, valid SSN but unknown birthplace. Subjects 
who received their SSN before 20 years of age were considered US-born whereas those who 
received an SSN when they were aged ≥ 20 years were considered foreign-born. This age 
cutpoint was derived from a previous study of patients with cancer, comparing self-reported 
nativity with the registry data and by maximizing the predictive value and minimizing the 
misclassification based on receiver operating characteristic curves.23–25 The 2.9% of 
subjects with missing or invalid SSNs were assigned a nativity based on the age and nativity 
distribution of the overall sample.
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Neighborhood ethnic enclave status—Neighborhood ethnic enclave was measured 
using a previously described index that used principal components analysis from the 
following 2000 Census block group variables: percentage linguistically isolated, percentage 
linguistically isolated who speak Spanish, percentage speaking limited English, percentage 
Spanish-speaking who spoke limited English, percentage of recent immigrants, percentage 
Hispanic, and percentage foreign-born.26 Each cancer case was assigned to a neighborhood 
ethnic enclave quintile based on the distribution across all census block groups in California. 
We dichotomized ethnic enclave into lower ethnic enclave (quintiles 1, 2, and 3) and higher 
ethnic enclave (quintiles 4 and 5) for statistical analysis.
Neighborhood SES—Neighborhood SES was measured using a previously described 
index that incorporates 2000 Census data regarding education, occupation, unemployment, 
household income, and poverty.27 Each cancer case was then assigned to a neighborhood 
SES quintile based on the distribution of SES across all census block groups in California. 
We dichotomized SES into lower SES (quintiles 1, 2, and 3) and higher SES (quintiles 4 and 
5) for statistical analysis. Individual-level information regarding SES is not collected by the 
CCR.
Follow-up—Survival time, in months, was calculated from date of diagnosis to whichever 
of the following occurred first: 1) date of death due to prostate cancer; 2) date of last known 
contact; or 3) December 31, 2010 (the end of the study period). Subjects who were missing 
the month or day of the month for either diagnosis or follow-up were given the imputed 
month of July and the 15th day of the month, respectively (1.7% with missing month and 
9.5%for whom the day of the month was missing). Deaths due to prostate cancer were 
identified from the underlying cause of death on the death certificate, according to the 9th28 
or 10th29 revisions of the ICD codes (ICD-9 code 1859, ICD-10 code C61.9). Of the 25,653 
individuals still alive at the end of the study period, 98.4% of US-born men had complete 
follow-up within the last 3 years (97% in the last year), whereas foreign-born men had 
slightly worse follow-up (96% within the past 3 years, 93% within the past year).
Statistical Analysis
We used Cox proportional hazards models stratified by stage of disease (local/regional, 
advanced, unknown) and adjusted for age to assess the effect of nativity on prostate cancer-
specific survival. Stratified Cox models allow the baseline hazard to vary within the different 
stage strata while assuming that the general relationship between survival and nativity 
remains the same, yielding 1 set of parameter estimates from a global model. The hazards 
ratio (HR) and 95% confidence intervals (95% CI) were estimated comparing foreign-born 
with US-born individuals. Because we were interested in examining the effect of 
neighborhood ethnic enclave on the relationship between survival and nativity, after testing 
the 2-way interaction, we computed models within the 2 levels of ethnic enclave. We then 
adjusted these models for year of diagnosis, marital status, histological grade, surgery, 
radiotherapy, hormone therapy, and neighborhood SES.
We found minimal spatial clustering of prostate cancer cases at the block group level; 65% 
of block groups had only 1 or 2 cases, 92% had ≤ 5 cases, and 99% had ≤ 10 cases. The 
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proportional hazards assumption was assessed by analysis of the scaled Schoenfeld residuals 
and no significant violations were observed.
RESULTS
Sociodemographic and clinical characteristics of the cases are shown in Table 1 by nativity 
and stratified by neighborhood ethnic enclave. The case population had a higher percentage 
of foreign-born (56%) individuals who were slightly older at the time of diagnosis compared 
with US-born individuals, especially within low ethnic enclaves. Foreign-born Hispanics 
were more likely to be diagnosed with disease of both advanced stage and advanced grade. 
Foreign-born Hispanics were more likely to undergo surgery or hormone therapy and less 
likely to receive radiotherapy. Foreign-born Hispanics were more likely to live in high ethnic 
enclave neighborhoods (72.2% vs 49.9% of US-born) and less likely to live in higher SES 
neighborhoods (21.1% vs 33.2% of US-born).
The unadjusted relationship between nativity and survival, stratified by ethnic enclave, for 
prostate cancer survival can be seen in the Kaplan-Meier curves shown in Figure 1. Overall, 
Foreign-born Hispanics living in a high ethnic enclave area were found to have better 
prostate cancer survival than their US-born counterparts; however, within low ethnic enclave 
areas, the survival curves were comparable between foreign-born and US-born Hispanics. 
The HRs of the fully adjusted Cox proportional hazards models for foreign-born Hispanics 
compared with US-born Hispanics are shown in Table 2. In these stage-stratified, age-
adjusted models, foreign-born Hispanics had significantly better survival (HR, 0.81; 95% CI, 
0.75–0.87). Ethnic enclave modified this effect (interaction P value of 0.009), with the 
survival advantage being more pronounced in the high ethnic enclave compared with low 
ethnic enclave neighborhoods. The HRs remained roughly the same after adjustment for 
significant personal and tumor characteristics as well as neighborhood SES.
To account for the possibility that many of the foreign-born Hispanics diagnosed with 
advanced disease may have left the country and thus their deaths may not have been 
captured by the registry, we performed a sensitivity analysis assuming that these individuals 
had died (n = 47). In the fully adjusted model, the survival results changed a small amount 
toward the null (HR, 0.84; 95% CI, 0.78–0.90). Because only 4.4% of cases with localized/
regional stage among foreign-born Hispanics, died of prostate cancer, we believed that 
limiting the sensitivity analysis to the cases with advanced disease was a reasonable 
assumption.
DISCUSSION
Given the overall SES disadvantage of Hispanic Americans compared with NH white 
Americans, it remains unclear why Hispanic Americans appear to consistently experience 
better outcomes across several health indicators relative to NH whites.15,30–33 Studies on 
Hispanic populations are distinctively well positioned to investigate whether migration-
related factors may help to describe these paradoxical patterns.12 Of particular interest, the 
Hispanic paradox has been attributed to better health outcomes specific to foreign-born 
Hispanics and indeed, previous studies have demonstrated that foreign-born Hispanics may 
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possess certain culturally related health protective effects against cancer mortality.9,17,31 To 
evaluate whether clinical or neighborhood-level social factors may help to explain nativity-
related differences in survival after a diagnosis of prostate cancer among Hispanic men, we 
used data from the large population-based CCR enhanced with neighborhood-level measures 
of ethnic enclave and SES.
To the best of our knowledge, the current study is the first to evaluate prostate cancer 
survival differences among Hispanics by ethnic enclave status. These findings support the 
growing body of evidence suggesting that prostate cancer survival among Hispanic men 
varies by nativity and acculturation-related factors.8,9 Singh et al demonstrated the 
importance of nativity for Hispanic Americans, demonstrating a more favorable covariate-
adjusted prostate cancer-specific risk of death among US Hispanic immigrants.9 For 
acculturation-related factors, a spatial scan conducted in Texas indicated that clustering of 
lifestyle factors by county of residence was associated with prostate cancer mortality.8 The 
current study extends these findings by jointly investigating the effects of nativity and 
residence in an ethnic enclave and demonstrating that, within the Hispanic American 
population, foreign-born individuals have an even greater survival advantage than US-born 
individuals. Neighborhood ethnic enclave status appeared to modify that effect, 
strengthening the nativity association in high ethnic enclave neighborhoods.
Previous studies have suggested that lifestyle factors including diet, physical activity, body 
mass index, smoking history, and social support may mediate the observed overall survival 
benefit experienced by Hispanic immigrants.15,33–38 Data from the 2000 National Health 
Interview Survey indicate that Hispanics with less English language use were more adherent 
to multiple health behavior recommendations such as tobacco and alcohol use and fruit and 
vegetable consumption.36 Likewise, ethnic enclaves may reflect the extent to which 
Hispanic communities maintained the traditional, more healthful, lifestyle factors of their 
home countries before immigration. Ethnic enclaves may also confer more coethnic social 
support and networks, a mechanism that has been hypothesized as an explanation for the 
Hispanic paradox. Indeed, studies have identified a range of health advantages for Hispanic 
immigrants living in ethnic enclaves26,39 and also among Hispanics of lower SES.40 Models 
of acculturation and acculturative stress have been developed to conceptualize processes by 
which Hispanic immigrants may become integrated or separated from the US host society 
and the associated health effects of those processes.41 Qualitative research provides a more 
descriptive picture of how ethnic enclaves may act as support systems not only to maintain 
Hispanic cultural mores but also to shield immigrants from exposure to the possible effects 
of stigmatizing messages that exist in the racial dynamics in the United States.15 Our novel 
findings of better survival among foreign-born Hispanics in ethnic enclaves directs future 
research into possible protective factors unexplained by clinical factors and neighborhood 
SES, as well as to what extent these factors may help to explain observed survival 
differences (eg, diet, physical activity, social support, tangible support, translator assistance, 
and community resources). Moreover, further etiologic research is warranted to tease apart 
the independent and joint effects and mechanisms of lifestyle factors underlying the 
dynamics between nativity and ethnic enclave status that may help to inform interventions 
for improving cancer survivorship outcomes.
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The strengths of the current study include the large, population-based data set; complete 
nativity information based on a validated imputation method; and incorporation of small-
area–level neighborhood factors. However, similar to all population-based cancer registry 
analyses, it lacked detailed individual-level data regarding risk factors and was limited by 
some degree of missing data and/or nonstandardized assessment of Hispanic race/ethnicity 
and nativity constituting the basis for cancer registry abstraction.19,20,42 For race/ethnicity, a 
previous study from the Greater Bay Area Cancer Registry, a subset of the CCR, found that 
compared with self-report, the sensitivity and positive predictive value for Hispanics were 
moderate (70%–90%)43; however, Hispanic classification was likely improved in this study 
with the application of an algorithm to enhance classification based on surnames, given 
names, and birthplace.21 For nativity, another Greater Bay Area Cancer Registry report 
demonstrated that when registry birthplace was recorded, it was highly accurate,18 including 
high accuracy for death certificates.44 Our measurement of nativity relied on imputation for 
the 40% of patients with prostate cancer for whom registry data regarding birthplace were 
missing.
The current study findings of survival differences may also have been biased by the “healthy 
immigrant” hypothesis, the phenomenon of migrants entering the United States with 
healthier baseline characteristics,33,45–47 or by the “salmon effect,” in which migrants with 
serious illnesses return home to their birth countries to die.32,48,49 Due to the lack of detailed 
individual-level prostate cancer risk factor information available in the registry setting, we 
were unable to account for the possible impact of the healthy immigrant hypothesis. 
However, we demonstrated statistically that the salmon migration effect would not have 
likely biased our results by performing a sensitivity analysis in which all foreign-born 
patients with disease of advanced stage and who were lost to follow-up were assumed to be 
dead; this slightly shifted our results toward the null, but our findings remained statistically 
significant. An additional limitation inherent to cancer registry analyses is residual 
confounding by factors for which we lack information or detailed information, including 
detailed treatment and comorbidities.13,14,50
Conclusions
Despite the tendency toward a later stage of prostate cancer at the time of diagnosis and a 
greater likelihood of living in lower SES neighborhoods and Hispanic ethnic enclaves, 
foreign-born Hispanics were found to have better survival after prostate cancer than US-born 
Hispanics, a finding that is consistent with the Hispanic paradox. Further research is needed 
to examine the reasons for the observed paradox, because identifying factors that facilitate 
this survival advantage in Hispanic immigrants may improve survival for all men with 
prostate cancer.
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Figure 1. 
Kaplan-Meier survival curves are shown for the unadjusted relationship between nativity and 
ethnic enclave for California Hispanic men diagnosed with prostate cancer from 1995 
through 2008.
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TABLE 2
Stratified Cox Proportional Hazards Model by Nativity for Hispanic Men With Prostate Cancer, Unstratified 
and Stratified by Ethnic Enclave: California, 1995 to 2008a
Cancer-Specific Survival
Variable Unstratified HR (95% CI) High Ethnic Enclave HR (95% CI) Low Ethnic Enclave HR (95% CI)
Nativity
  US born 1.00 1.00 1.00
  Foreign born 0.81 (0.75–0.88) 0.78 (0.71–0.86) 0.86 (0.76–0.98)
Age 1.04 (1.03–1.05) 1.04 (1.03–1.05) 1.05 (1.04–1.06)
Marital status
  Married 1.00 1.00 1.00
  Never married 1.13 (1.00–1.28) 1.17 (1.01–1.35) 1.02 (0.80–1.29)
  Previously married 1.15 (1.04–1.28) 1.13 (1.00–1.27) 1.21 (1.02–1.43)
  Unknown 0.91 (0.79–1.05) 0.89 (0.75–1.06) 0.96 (0.75–1.23)
Tumor grade
  I 0.74 (0.57–0.96) 0.76 (0.55–1.03) 0.68 (0.41–1.13)
  II 1.00 1.00 1.00
  III 2.66 (2.42–2.91) 2.66 (2.38–2.98) 2.65 (2.26–3.10)
  IV 2.82 (2.04–3.90) 3.16 (2.20–4.56) 2.02 (0.98–4.15)
  Unknown 3.18 (2.80–3.60) 3.26 (2.80–3.80) 2.97 (2.37–3.71)
Surgery
  No 1.00 1.00 1.00
  Yes 0.74 (0.66–0.82) 0.75 (0.66–0.85) 0.69 (0.57–0.84)
  Unknown 1.62 (0.88–2.97) 1.29 (0.53–3.15) 2.21 (0.94–5.18)
Radiotherapy
  No 1.00 1.00 1.00
  Yes 0.83 (0.76–0.91) 0.87 (0.78–0.97) 0.79 (0.67–0.92)
  Unknown 2.16 (0.47–9.95) 3.49 (0.40–30.5) 1.41 (0.16–12.3)
Hormone therapy
  No 1.00 1.00 1.00
  Yes 1.73 (1.58–1.90) 1.70 (1.52–1.91) 1.76 (1.50–2.06)
  Unknown 1.07 (0.77–1.47) 1.05 (0.71–1.55) 1.02 (0.56–1.85)
Neighborhood SES
  High 1.00 1.00 1.00
  Low 1.13 (1.05–1.22) 1.12 (1.01–1.25) 1.10 (0.94–1.29)
Abbreviations: 95% CI, 95% confidence interval; HR, hazards ratio; SES, socioeconomic status.
a
Follow-up through December 31, 2010.
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